1. Home
  2. FATE vs FCAP Comparison

FATE vs FCAP Comparison

Compare FATE & FCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • FCAP
  • Stock Information
  • Founded
  • FATE 2007
  • FCAP 1891
  • Country
  • FATE United States
  • FCAP United States
  • Employees
  • FATE N/A
  • FCAP N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • FCAP Savings Institutions
  • Sector
  • FATE Health Care
  • FCAP Finance
  • Exchange
  • FATE Nasdaq
  • FCAP Nasdaq
  • Market Cap
  • FATE 177.7M
  • FCAP 161.2M
  • IPO Year
  • FATE 2013
  • FCAP 1999
  • Fundamental
  • Price
  • FATE $1.18
  • FCAP $43.48
  • Analyst Decision
  • FATE Hold
  • FCAP
  • Analyst Count
  • FATE 7
  • FCAP 0
  • Target Price
  • FATE $3.83
  • FCAP N/A
  • AVG Volume (30 Days)
  • FATE 2.0M
  • FCAP 6.8K
  • Earning Date
  • FATE 08-12-2025
  • FCAP 07-25-2025
  • Dividend Yield
  • FATE N/A
  • FCAP 2.64%
  • EPS Growth
  • FATE N/A
  • FCAP 2.61
  • EPS
  • FATE N/A
  • FCAP 3.65
  • Revenue
  • FATE $13,335,000.00
  • FCAP $42,869,000.00
  • Revenue This Year
  • FATE N/A
  • FCAP N/A
  • Revenue Next Year
  • FATE N/A
  • FCAP N/A
  • P/E Ratio
  • FATE N/A
  • FCAP $12.04
  • Revenue Growth
  • FATE 105.85
  • FCAP 6.35
  • 52 Week Low
  • FATE $0.66
  • FCAP $27.71
  • 52 Week High
  • FATE $5.92
  • FCAP $53.85
  • Technical
  • Relative Strength Index (RSI)
  • FATE 46.59
  • FCAP 38.73
  • Support Level
  • FATE $1.16
  • FCAP $43.54
  • Resistance Level
  • FATE $1.32
  • FCAP $47.55
  • Average True Range (ATR)
  • FATE 0.16
  • FCAP 1.79
  • MACD
  • FATE -0.04
  • FCAP -0.44
  • Stochastic Oscillator
  • FATE 8.33
  • FCAP 15.52

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About FCAP First Capital Inc.

First Capital Inc is the financial holding company of First Harrison Bank. Through its subsidiary, it operates as a federally-chartered savings bank that provides banking services to individuals and business customers across locations in America. The bank offers various loans which include residential loans, construction loans, commercial real estate loans and commercial business loans. It also provides consumer loans such as home equity and second mortgage loans, and automobile and truck loans.

Share on Social Networks: